Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma.
Saved in:
| Title: | Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma. |
|---|---|
| Authors: | Zhang X; Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site University Hospital Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany., Zegar T; Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site University Hospital Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany., Weiser T; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt, Germany.; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Network (DKTK), Frankfurt, Germany., Hamdan FH; Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany.; Gene Regulatory Mechanisms and Molecular Epigenetics Lab, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Berger BT; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt, Germany.; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany., Lucas R; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt, Germany.; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Network (DKTK), Frankfurt, Germany., Balourdas DI; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt, Germany.; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany., Ladigan S; Department of Molecular Gastrointestinal Oncology, Ruhr-University Bochum, Bochum, Germany.; Department of Internal Medicine, Knappschaftskrankenhaus Bochum, Ruhr-University of Bochum, Bochum, Germany., Cheung PF; Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site University Hospital Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany., Liffers ST; Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site University Hospital Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany., Trajkovic-Arsic M; Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site University Hospital Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany., Scheffler B; DKFZ Division of Translational Neurooncology, West German Cancer Center, DKTK partner site University Hospital Essen, Essen, Germany., Joerger AC; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt, Germany.; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Network (DKTK), Frankfurt, Germany., Hahn SA; Department of Molecular Gastrointestinal Oncology, Ruhr-University Bochum, Bochum, Germany., Johnsen SA; Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany.; Gene Regulatory Mechanisms and Molecular Epigenetics Lab, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Knapp S; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt, Germany.; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Network (DKTK), Frankfurt, Germany., Siveke JT; Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site University Hospital Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany. |
| Source: | International journal of cancer [Int J Cancer] 2020 Nov 15; Vol. 147 (10), pp. 2847-2861. Date of Electronic Publication: 2020 Jun 29. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32599645 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site University Hospital Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Zegar+T%22">Zegar T</searchLink>; Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site University Hospital Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Weiser+T%22">Weiser T</searchLink>; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt, Germany.; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Network (DKTK), Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Hamdan+FH%22">Hamdan FH</searchLink>; Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany.; Gene Regulatory Mechanisms and Molecular Epigenetics Lab, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Berger+BT%22">Berger BT</searchLink>; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt, Germany.; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Lucas+R%22">Lucas R</searchLink>; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt, Germany.; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Network (DKTK), Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Balourdas+DI%22">Balourdas DI</searchLink>; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt, Germany.; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Ladigan+S%22">Ladigan S</searchLink>; Department of Molecular Gastrointestinal Oncology, Ruhr-University Bochum, Bochum, Germany.; Department of Internal Medicine, Knappschaftskrankenhaus Bochum, Ruhr-University of Bochum, Bochum, Germany.<br /><searchLink fieldCode="AU" term="%22Cheung+PF%22">Cheung PF</searchLink>; Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site University Hospital Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Liffers+ST%22">Liffers ST</searchLink>; Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site University Hospital Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Trajkovic-Arsic+M%22">Trajkovic-Arsic M</searchLink>; Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site University Hospital Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Scheffler+B%22">Scheffler B</searchLink>; DKFZ Division of Translational Neurooncology, West German Cancer Center, DKTK partner site University Hospital Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Joerger+AC%22">Joerger AC</searchLink>; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt, Germany.; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Network (DKTK), Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Hahn+SA%22">Hahn SA</searchLink>; Department of Molecular Gastrointestinal Oncology, Ruhr-University Bochum, Bochum, Germany.<br /><searchLink fieldCode="AU" term="%22Johnsen+SA%22">Johnsen SA</searchLink>; Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany.; Gene Regulatory Mechanisms and Molecular Epigenetics Lab, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Knapp+S%22">Knapp S</searchLink>; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt, Germany.; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Network (DKTK), Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Siveke+JT%22">Siveke JT</searchLink>; Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site University Hospital Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220042124%22">International journal of cancer</searchLink> [Int J Cancer] 2020 Nov 15; Vol. 147 (10), pp. 2847-2861. <i>Date of Electronic Publication: </i>2020 Jun 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0042124 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200207136%22">00207136 </searchLink><i>NLM ISO Abbreviation: </i>Int J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32599645 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ijc.33137 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2847 Titles: – TitleFull: Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang X – PersonEntity: Name: NameFull: Zegar T – PersonEntity: Name: NameFull: Weiser T – PersonEntity: Name: NameFull: Hamdan FH – PersonEntity: Name: NameFull: Berger BT – PersonEntity: Name: NameFull: Lucas R – PersonEntity: Name: NameFull: Balourdas DI – PersonEntity: Name: NameFull: Ladigan S – PersonEntity: Name: NameFull: Cheung PF – PersonEntity: Name: NameFull: Liffers ST – PersonEntity: Name: NameFull: Trajkovic-Arsic M – PersonEntity: Name: NameFull: Scheffler B – PersonEntity: Name: NameFull: Joerger AC – PersonEntity: Name: NameFull: Hahn SA – PersonEntity: Name: NameFull: Johnsen SA – PersonEntity: Name: NameFull: Knapp S – PersonEntity: Name: NameFull: Siveke JT IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 11 Text: 2020 Nov 15 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1097-0215 Numbering: – Type: volume Value: 147 – Type: issue Value: 10 Titles: – TitleFull: International journal of cancer Type: main |
| ResultId | 1 |